| Value | ₹1.19 Cr |
|---|
BSE filing, NSE: BROOKS. Summary written from the filing by ALFA Finder's alert engine.
Brooks Laboratories Ltd: key numbers
- Share price
- ₹63.02
- Market cap
- ₹185.6 Cr
- Revenue (annual)
- ₹85.74 Cr
- Net profit (annual)
- ₹24.58 Cr
- P/E (TTM)
- 14.1×Sector 46.1×
- Promoter holding
- 52.62%+0.00% QoQ
- FII holding
- 0.04%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Brooks Laboratories Ltd
All →Brooks Laboratories Other Announcement
Brooks Laboratories Ltd has submitted its quarterly shareholding pattern as of September 30, 2026, in compliance with SEBI regulatory requirements.
Brooks Laboratories Merger & Restructuring
Brooks Laboratories approved a demerger of its Manufacturing Business into its wholly-owned subsidiary, Abridge Speciality Limited, through a scheme of arrangement.
Brooks Laboratories Price Movement Clarification
Brooks Laboratories informed BSE it has no additional material information to disclose regarding the recent price movement. The company attributed the share price and volume changes to purely market-driven factors.
Brooks Laboratories Management Change
Brooks Laboratories Ltd announced the resignation of Ms. Krutika Rane, Company Secretary and Compliance Officer, effective October 9, 2026.
Brooks Laboratories Annual General Meeting
Brooks Laboratories Limited conducted its 24th Annual General Meeting on September 3, 2026. Shareholders transacted ordinary business, including the adoption of financial statements and director appointments.
Brooks Laboratories Annual General Meeting
Brooks Laboratories issued an addendum to its 24th Annual General Meeting notice. The amendment modifies Resolution No. 4 regarding corporate guarantee arrangements.
Other debt & borrowing announcements
All →Autofurnish Debt & Borrowing: ₹10.1 Cr
Autofurnish Ltd is availing a Rs. 10.10 Crore SBI Cash Credit facility and transferring a Rs. 5 Crore Axis Bank loan. Tenure is 365 days at 8.60%.
- Value
- ₹10.10 Cr
Poonawalla Fincorp Debt & Borrowing: ₹1,318 Cr
Poonawalla Fincorp allotted Rs 1,318 Crore NCDs across two series G1 and G2. The allotment comprises zero-coupon and 9% coupon debentures maturing by 2030.
- Value
- ₹1,318 Cr
Fusion Finance Debt & Borrowing: ₹1.35 Cr
Fusion Finance Limited paid Rs.1.35 Crore monthly interest on its non-convertible debentures on 28 October 2026. The payment was made on time, one day ahead of the stated due date of 29 October 2026.
- Value
- ₹1.35 Cr
Bajaj Finance Debt & Borrowing: ₹300 Cr
Bajaj Life Insurance purchased 30,000 NCDs of Bajaj Finance worth ₹300 Crore on NSE. The open-market debt buy signals promoter confidence in the company.
- Value
- ₹300.0 Cr
Fusion CX Debt & Borrowing: ₹21.85 Cr
Fusion CX lent up to Rs.21.85 Crore (USD 2.3 million) to wholly owned subsidiary Fusion BPO Services. Terms: 8.5% interest, three-year tenure, unsecured.
- Value
- ₹21.85 Cr
- Execution
- 3 years from the date of disbursal
Fusion CX Debt & Borrowing
Fusion CX Limited executed an unsecured inter-corporate term loan at 8.5% p.a. for three years with its wholly owned subsidiary Fusion BPO Services Ltd, a related party. Amount is not stated in the filing.
- Execution
- 3 years from the date of disbursal